Announcements

Current Issue

Vol 3 No 1 (2022): Journal of Pharmacovigilance and Drug Research

Published on March 1, 2022.

1. Effects of COVID-19 pandemic on the conduct of clinical trials

2. A review of pharmacovigilance

3. Adverse drug reactions reported during pregnancy and associated congenital disorders

4. Incidence and risk factors for oxaliplatin-induced vascular pain during administration in Iraqi patients

5. Knowledge, attitude, and practice among Ayurvedic scholars and trainees towards pharmacovigilance: a questionnaire-based survey in Gujarat, India

6. A rare case report of linezolid induced thrombocytopenia

Published: 2022-03-01
View All Issues

The Journal of Pharmacovigilance and Drug Research (JPADR) is the official publication of the Global Pharmacovigilance Society. This is an international, open access, and peer-reviewed scientific journal. It focuses on pharmacovigilance studies and their associated topics such as adverse drug reaction, drug clinical trials, drug effectiveness and efficacy, drugs risk management, as well as all aspects related to the safe use of drugs.

The JPADR is oriented to researchers, professors, students, and practitioners from both the pharmaceutical industry sector, as well as the wide range of health and medicine arenas. The journal’s objective is to establish a formal platform for communicating the research results on pharmacovigilance.

An official publication of Global Pharmacovigilance Society

“A goal towards patient safety and drug safety”

 

Abstracting and Indexing: National Digital Library of India, Google Scholar, Geneva foundation for medical education and research, J-Gate, ResearchBib, EuroPub, Zenodo, OpenAIRE, and more.

Contact: editor@jpadr.com/ editor.jpadr@gmail.com

Editor-in-Chief: Dr.Chinmaya Mahapatra, M.Pharm, Ph D.